Skip to main content

Goat Polyclonal DAGLA antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 8 publications. Immunogen corresponding to Synthetic Peptide within Human DAGLA aa 1000 to C-terminus.


Images

Western blot - Anti-DAGLA antibody (AB81984), expandable thumbnail

Publications

Key facts

Isotype
IgG
Host species
Goat
Storage buffer

pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: 0.5% BSA, 0.5% Tris buffered saline

Form
Liquid
Clonality
Polyclonal

Immunogen

  • Synthetic Peptide within Human DAGLA aa 1000 to C-terminus. The exact immunogen used to generate this antibody is proprietary information. Database link Q9Y4D2

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
WBIHC-P
Human
Tested
Expected

Tested
Tested

Species
Human
Dilution info
0.3-1 µg/mL
Notes

1 hour primary incubation is recommended for this product.

Expected
Expected

Species
Human
Dilution info
Use at an assay dependent concentration.
Notes

-

Target data

Function

Serine hydrolase that hydrolyzes arachidonic acid-esterified diacylglycerols (DAGs) to produce the principal endocannabinoid, 2-arachidonoylglycerol (2-AG) (PubMed:14610053, PubMed:23502535, PubMed:26668358). Preferentially hydrolyzes sn-1 fatty acids from diacylglycerols (DAG) that contain arachidonic acid (AA) esterified at the sn-2 position to biosynthesize 2-AG (PubMed:14610053, PubMed:23502535, PubMed:26668358). Has negligible activity against other lipids including monoacylglycerols and phospholipids (PubMed:14610053). Plays a key role in regulating 2-AG signaling in the central nervous system (CNS). Regulates 2-AG involved in retrograde suppression at central synapses. Supports axonal growth during development and adult neurogenesis. Plays a role for eCB signaling in the physiological regulation of anxiety and depressive behaviors. Regulates also neuroinflammatory responses in the brain, in particular, LPS-induced microglial activation (By similarity).

Alternative names

Recommended products

Goat Polyclonal DAGLA antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 8 publications. Immunogen corresponding to Synthetic Peptide within Human DAGLA aa 1000 to C-terminus.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Polyclonal
Immunogen
  • Synthetic Peptide within Human DAGLA aa 1000 to C-terminus. The exact immunogen used to generate this antibody is proprietary information. Database link Q9Y4D2
Purification technique
Affinity purification Immunogen
Concentration
Loading...
Purification notes

Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Western blot - Anti-DAGLA antibody (ab81984), expandable thumbnail

    Western blot - Anti-DAGLA antibody (ab81984)

    Some minor background is detected and is blocked by the immunizing peptide.

    Primary incubation for 1 hour. Detected by chemiluminescence.

    All lanes: Western blot - Anti-DAGLA antibody (ab81984) at 0.3 µg/mL

    All lanes: human liver lysate (in RIPA buffer) at 35 µg

    Developed using the ECL technique.

    Predicted band size: 114 kDa

    Observed band size: 125 kDa, 22 kDa, 55 kDa

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com